Skip to main content
Sinocelltech Group Limited logo

Sinocelltech Group Limited — Investor Relations & Filings

Ticker · 688520 ISIN · CNE100003ZL3 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 659 across all filing types
Latest filing 2025-04-25 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688520

About Sinocelltech Group Limited

https://www.sinocelltech.com/

Sinocelltech Group Limited focuses on the research, development, and commercialization of innovative biologics, including monoclonal antibodies, recombinant proteins, and vaccine candidates. The company's product pipeline addresses therapeutic areas such as oncology, autoimmune disorders, hematology, and infectious diseases. Key offerings include recombinant human coagulation factor VIII for hemophilia A and a range of biosimilars. Sinocelltech leverages an integrated technology platform encompassing early-stage discovery through to large-scale industrial production. This infrastructure supports the development of high-quality biological medicines aimed at addressing unmet medical needs through advanced protein engineering and cell line development.

Recent filings

Filing Released Lang Actions
神州细胞2024年度独立董事述职报告（苏志国）
Board/Management Information Classification · 95% confidence The document is titled '2024年度独立董事述职报告' which translates to '2024 Annual Independent Director's Work Report'. It details the independent director's personal background, attendance and participation in board and committee meetings, review of company operations, internal control evaluation, audit firm appointment, and other governance-related activities during the year 2024. The content focuses on the independent director's duties, oversight, and evaluation of company governance and compliance rather than financial results or audit opinions. It is a detailed report on board/management oversight and director activities rather than a financial report, audit report, or regulatory announcement. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is over 5,000 characters and contains substantive content, so it is not a mere announcement or certification. Hence, the classification is MANG with high confidence.
2025-04-25 Chinese
神州细胞董事会审计委员会对会计师事务所履行监督职责情况报告
Audit Report / Information Classification · 95% confidence The document is a report from the Board Audit Committee regarding the supervision of the accounting firm (信永中和) for the 2024 annual audit of the company's financial statements and internal controls. It details the qualifications of the audit firm, the procedures for their appointment, communications during the audit process, and an overall evaluation of the audit firm's performance. The document does not contain the actual audited financial statements or detailed financial data but rather focuses on the oversight and supervisory role of the audit committee over the auditor's work. This matches the definition of an Audit Report / Information filing, which includes standalone audit reports and information about the audit process and applied accounting principles, excluding the full Annual Report. The document length is 1786 characters, which is short but contains substantive supervisory content rather than just an announcement. Therefore, the appropriate classification is AR (Audit Report / Information). FY 2024
2025-04-25 Chinese
董事会议事规则
Governance Information Classification · 100% confidence The document is titled "董事会议事规则" which translates to "Rules of Procedure for the Board of Directors" of Beijing Shenzhou Cell Technology Group Co., Ltd. The content details the procedures, rules, and governance related to the board meetings, including meeting types, proposal submission, voting, attendance, and record-keeping. There is no financial data, earnings information, or regulatory filings related to financial results. The document focuses on internal governance and board operation rules, which aligns with governance information. It is not an announcement or a report publication but a detailed governance document. Therefore, the appropriate classification is Governance Information (CGR).
2025-04-25 Chinese
神州细胞关于会计师事务所履职情况评估报告
Audit Report / Information Classification · 95% confidence The document is titled as an evaluation report on the performance of the accounting firm (信永中和会计师事务所) for the 2024 annual audit of the company. It details the auditor's qualifications, audit quality management, audit plan, resources, confidentiality, risk management, and overall evaluation of the auditor's performance during the 2024 audit. It does not contain the actual audited financial statements or detailed financial results of the company, but rather an assessment of the auditor's work and quality control. The document length is 3289 characters, which is relatively short and focused on audit quality and auditor evaluation. This matches the description of an Audit Report / Information (AR) which includes standalone audit reports, applied accounting principles, and results of internal or regulatory stress tests, excluding full annual reports. It is not an Annual Report (10-K) because it lacks comprehensive financial data and company activity details. It is not a Regulatory Filing (RNS) because it is a substantive report on audit performance rather than a certification or miscellaneous announcement. Therefore, the correct classification is AR with high confidence. FY 2024
2025-04-25 Chinese
独立董事提名人声明与承诺（贾凌云）
Board/Management Information Classification · 95% confidence The document is a detailed statement and commitment regarding the nomination of an independent director candidate for a listed company on the Science and Technology Innovation Board (科创板). It includes qualifications, legal compliance, independence criteria, and declarations related to the nominee's suitability for the board position. There is no financial data, no report of financial results, no voting results, no announcement of a meeting, no legal proceeding update, and no mention of any other report type. This document is related to board/management information, specifically about the nomination of a board member. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is short (2064 characters), and it is not an announcement of a report but a substantive declaration about board nomination.
2025-04-25 Chinese
独立董事候选人声明与承诺（王浩峰）
Board/Management Information Classification · 95% confidence The document is a declaration and commitment statement by an independent director candidate for a listed company on the Science and Technology Innovation Board (科创板). It details the candidate's qualifications, compliance with regulatory requirements, and independence criteria. There is no financial data, no report or announcement of financial results, no voting results, no management changes, and no regulatory filings of other types. The document is a formal statement related to board/management information, specifically concerning the nomination and qualifications of a board member candidate. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is short and it is not an announcement of a report but a declaration by the candidate.
2025-04-25 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.